These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 11984584

  • 1. An array of possibilities for multiple sclerosis.
    Tompkins SM, Miller SD.
    Nat Med; 2002 May; 8(5):451-3. PubMed ID: 11984584
    [No Abstract] [Full Text] [Related]

  • 2. An array of sunshine in multiple sclerosis.
    Dyment DA, Ebers GC.
    N Engl J Med; 2002 Oct 31; 347(18):1445-7. PubMed ID: 12409550
    [No Abstract] [Full Text] [Related]

  • 3. Clinical, pathological, and immunologic aspects of the multiple sclerosis model in common marmosets (Callithrix jacchus).
    't Hart BA, Massacesi L.
    J Neuropathol Exp Neurol; 2009 Apr 31; 68(4):341-55. PubMed ID: 19337065
    [Abstract] [Full Text] [Related]

  • 4. Multiple sclerosis: human model for EAE?
    Hohlfeld R.
    Eur J Immunol; 2009 Aug 31; 39(8):2036-9. PubMed ID: 19672899
    [Abstract] [Full Text] [Related]

  • 5. [Morphological comparisons of disorders in multiple sclerosis and experimental allergic encephalomyelitis].
    Macheret EL, Iarosh AA, Korchemnyĭ VA, Panchenko LP.
    Vrach Delo; 1987 Dec 31; (12):64-8. PubMed ID: 3445573
    [No Abstract] [Full Text] [Related]

  • 6. Genomics in multiple sclerosis--current state and future directions.
    Comabella M, Martin R.
    J Neuroimmunol; 2007 Jul 31; 187(1-2):1-8. PubMed ID: 17400297
    [Abstract] [Full Text] [Related]

  • 7. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Vogt J, Paul F, Aktas O, Müller-Wielsch K, Dörr J, Dörr S, Bharathi BS, Glumm R, Schmitz C, Steinbusch H, Raine CS, Tsokos M, Nitsch R, Zipp F.
    Ann Neurol; 2009 Sep 31; 66(3):310-22. PubMed ID: 19798635
    [Abstract] [Full Text] [Related]

  • 8. MRI to predict severe tissue damage in inflammatory lesions in animal models of multiple sclerosis.
    Brochet B, Dousset V, Deloire M, Boiziau C, Petry KG.
    Brain; 2008 Mar 31; 131(Pt 3):e92. PubMed ID: 17965047
    [No Abstract] [Full Text] [Related]

  • 9. Rodent models of experimental allergic encephalomyelitis applied to the study of multiple sclerosis.
    Goverman J, Brabb T.
    Lab Anim Sci; 1996 Oct 31; 46(5):482-92. PubMed ID: 8905579
    [No Abstract] [Full Text] [Related]

  • 10. Decreased expression of VEGF-A in rat experimental autoimmune encephalomyelitis and in cerebrospinal fluid mononuclear cells from patients with multiple sclerosis.
    Tham E, Gielen AW, Khademi M, Martin C, Piehl F.
    Scand J Immunol; 2006 Dec 31; 64(6):609-22. PubMed ID: 17083617
    [Abstract] [Full Text] [Related]

  • 11. Medicine: Collateral damage repaired.
    Steinman L.
    Nature; 2003 Apr 17; 422(6933):671-2. PubMed ID: 12700743
    [No Abstract] [Full Text] [Related]

  • 12. Current gene-mapping strategies in experimental models of multiple sclerosis.
    Becanovic K, Jagodic M, Wallström E, Olsson T.
    Scand J Immunol; 2004 Apr 17; 60(1-2):39-51. PubMed ID: 15238072
    [Abstract] [Full Text] [Related]

  • 13. Exploiting genotypic differences to identify genes important for EAE development.
    Jelinsky SA, Miyashiro JS, Saraf KA, Tunkey C, Reddy P, Newcombe J, Oestreicher JL, Brown E, Trepicchio WL, Leonard JP, Marusic S.
    J Neurol Sci; 2005 Dec 15; 239(1):81-93. PubMed ID: 16214174
    [Abstract] [Full Text] [Related]

  • 14. Regulation of gene expression associated with acute experimental autoimmune encephalomyelitis by Lovastatin.
    Paintlia AS, Paintlia MK, Singh AK, Stanislaus R, Gilg AG, Barbosa E, Singh I.
    J Neurosci Res; 2004 Jul 01; 77(1):63-81. PubMed ID: 15197739
    [Abstract] [Full Text] [Related]

  • 15. Transcriptional profiling of multiple sclerosis: towards improved diagnosis and treatment.
    Lindberg RL, Kappos L.
    Expert Rev Mol Diagn; 2006 Nov 01; 6(6):843-55. PubMed ID: 17140371
    [Abstract] [Full Text] [Related]

  • 16. Neuroimmunoprotective effects of estrogen and derivatives in experimental autoimmune encephalomyelitis: therapeutic implications for multiple sclerosis.
    Offner H.
    J Neurosci Res; 2004 Dec 01; 78(5):603-24. PubMed ID: 15515048
    [Abstract] [Full Text] [Related]

  • 17. Multiple sclerosis and gene expression profiling.
    Steinman L.
    Adv Exp Med Biol; 2001 Dec 01; 490():109-12. PubMed ID: 11505968
    [No Abstract] [Full Text] [Related]

  • 18. Glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Reichardt HM, Gold R, Lühder F.
    Expert Rev Neurother; 2006 Nov 01; 6(11):1657-70. PubMed ID: 17144780
    [Abstract] [Full Text] [Related]

  • 19. Multiple sclerosis and gender.
    Darlington C.
    Curr Opin Investig Drugs; 2002 Jun 01; 3(6):911-4. PubMed ID: 12137412
    [No Abstract] [Full Text] [Related]

  • 20. Effective combination of minocycline and interferon-beta in a model of multiple sclerosis.
    Giuliani F, Fu SA, Metz LM, Yong VW.
    J Neuroimmunol; 2005 Aug 01; 165(1-2):83-91. PubMed ID: 15958276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.